Literature DB >> 29702372

Cerebrospinal fluid β-amyloid42 and neurofilament light relate to white matter hyperintensities.

Katie E Osborn1, Dandan Liu2, Lauren R Samuels3, Elizabeth E Moore1, Francis E Cambronero1, Lealani Mae Y Acosta1, Susan P Bell4, Michelle A Babicz1, Elizabeth A Gordon1, Kimberly R Pechman1, L Taylor Davis5, Katherine A Gifford1, Timothy J Hohman1, Kaj Blennow6, Henrik Zetterberg6, Angela L Jefferson7.   

Abstract

White matter hyperintensities (WMHs) are associated with poorer brain health, but their pathophysiological substrates remain elusive. To better understand the mechanistic underpinnings of WMHs among older adults, this study examined in vivo cerebrospinal fluid biomarkers of β-amyloid42 deposition (Aβ42), hyperphosphorylated tau pathology, neurodegeneration (total tau), and axonal injury (neurofilament light [NFL]) in relation to log-transformed WMHs volume. Participants free of clinical stroke and dementia were drawn from the Vanderbilt Memory & Aging Project (n = 148, 72 ± 6 years). Linear regression models adjusted for age, sex, race/ethnicity, education, intracranial volume, modified Framingham Stroke Risk Profile (excluding points assigned for age), cognitive diagnosis, and APOE-ε4 carrier status. Aβ42 (β = -0.001, p = 0.007) and NFL (β = 0.0003, p = 0.01) concentrations related to WMHs but neither hyperphosphorylated tau nor total tau associations with WMHs reached statistical significance (p-values > 0.21). In a combined model, NFL accounted for 3.2% of unique variance in WMHs and Aβ42 accounted for an additional 4.3% beyond NFL, providing novel evidence of the co-occurrence of at least 2 distinct pathways for WMHs among older adults, including amyloid deposition and axonal injury.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Amyloid; Cerebrospinal fluid; Dementia; Neurofilament light; White matter hyperintensities; β-amyloid(42)

Mesh:

Substances:

Year:  2018        PMID: 29702372      PMCID: PMC6085839          DOI: 10.1016/j.neurobiolaging.2018.03.028

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  49 in total

1.  CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease.

Authors:  Katharina Buerger; Michael Ewers; Tuula Pirttilä; Raymond Zinkowski; Irina Alafuzoff; Stefan J Teipel; John DeBernardis; Daniel Kerkman; Cheryl McCulloch; Hilkka Soininen; Harald Hampel
Journal:  Brain       Date:  2006-09-29       Impact factor: 13.501

2.  The effect of white matter hyperintensities on neurodegeneration in mild cognitive impairment.

Authors:  Giuseppe Tosto; Molly E Zimmerman; Jamie L Hamilton; Owen T Carmichael; Adam M Brickman
Journal:  Alzheimers Dement       Date:  2015-06-13       Impact factor: 21.566

3.  White matter signal abnormalities in normal individuals: correlation with carotid ultrasonography, cerebral blood flow measurements, and cerebrovascular risk factors.

Authors:  F Fazekas; K Niederkorn; R Schmidt; H Offenbacher; S Horner; G Bertha; H Lechner
Journal:  Stroke       Date:  1988-10       Impact factor: 7.914

4.  White matter hyperintensities predict amyloid increase in Alzheimer's disease.

Authors:  Timo Grimmer; Maximilian Faust; Florian Auer; Panagiotis Alexopoulos; Hans Förstl; Gjermund Henriksen; Robert Perneczky; Christian Sorg; Behrooz H Yousefi; Alexander Drzezga; Alexander Kurz
Journal:  Neurobiol Aging       Date:  2012-03-10       Impact factor: 4.673

5.  Relation between age-related decline in intelligence and cerebral white-matter hyperintensities in healthy octogenarians: a longitudinal study.

Authors:  E Garde; E L Mortensen; K Krabbe; E Rostrup; H B Larsson
Journal:  Lancet       Date:  2000-08-19       Impact factor: 79.321

6.  White matter hyperintensities and amyloid are independently associated with entorhinal cortex volume among individuals with mild cognitive impairment.

Authors:  Vanessa A Guzman; Owen T Carmichael; Christopher Schwarz; Giuseppe Tosto; Molly E Zimmerman; Adam M Brickman
Journal:  Alzheimers Dement       Date:  2013-01-30       Impact factor: 21.566

7.  Increased in vivo amyloid-β42 production, exchange, and loss in presenilin mutation carriers.

Authors:  Rachel Potter; Bruce W Patterson; Donald L Elbert; Vitaliy Ovod; Tom Kasten; Wendy Sigurdson; Kwasi Mawuenyega; Tyler Blazey; Alison Goate; Robert Chott; Kevin E Yarasheski; David M Holtzman; John C Morris; Tammie L S Benzinger; Randall J Bateman
Journal:  Sci Transl Med       Date:  2013-06-12       Impact factor: 17.956

8.  Association of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: the Framingham Offspring Study.

Authors:  Stéphanie Debette; Alexa Beiser; Charles DeCarli; Rhoda Au; Jayandra J Himali; Margaret Kelly-Hayes; Jose R Romero; Carlos S Kase; Philip A Wolf; Sudha Seshadri
Journal:  Stroke       Date:  2010-02-18       Impact factor: 7.914

9.  Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration.

Authors:  Joanna M Wardlaw; Eric E Smith; Geert J Biessels; Charlotte Cordonnier; Franz Fazekas; Richard Frayne; Richard I Lindley; John T O'Brien; Frederik Barkhof; Oscar R Benavente; Sandra E Black; Carol Brayne; Monique Breteler; Hugues Chabriat; Charles Decarli; Frank-Erik de Leeuw; Fergus Doubal; Marco Duering; Nick C Fox; Steven Greenberg; Vladimir Hachinski; Ingo Kilimann; Vincent Mok; Robert van Oostenbrugge; Leonardo Pantoni; Oliver Speck; Blossom C M Stephan; Stefan Teipel; Anand Viswanathan; David Werring; Christopher Chen; Colin Smith; Mark van Buchem; Bo Norrving; Philip B Gorelick; Martin Dichgans
Journal:  Lancet Neurol       Date:  2013-08       Impact factor: 44.182

10.  Cerebrovascular Biomarker Profile Is Related to White Matter Disease and Ventricular Dilation in a LADIS Substudy.

Authors:  Maria Bjerke; Michael Jonsson; Arto Nordlund; Carl Eckerström; Kaj Blennow; Henrik Zetterberg; Leonardo Pantoni; Domenico Inzitari; Reinhold Schmidt; Anders Wallin
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2014-10-21
View more
  14 in total

Review 1.  Cerebral small vessel disease: neuroimaging markers and clinical implication.

Authors:  Xiaodong Chen; Jihui Wang; Yilong Shan; Wei Cai; Sanxin Liu; Mengyan Hu; Siyuan Liao; Xuehong Huang; Bingjun Zhang; Yuge Wang; Zhengqi Lu
Journal:  J Neurol       Date:  2018-10-05       Impact factor: 4.849

2.  Elevated CSF neurofilament light chain concentration in a patient with facial onset sensory and motor neuronopathy.

Authors:  Kristin S Lange; André Maier; Christoph Leithner
Journal:  Neurol Sci       Date:  2019-08-06       Impact factor: 3.307

3.  Axonal Injury Partially Mediates Associations Between Increased Left Ventricular Mass Index and White Matter Damage.

Authors:  Elizabeth E Moore; Omair A Khan; Niranjana Shashikumar; Kimberly R Pechman; Dandan Liu; Susan P Bell; Sangeeta Nair; James G Terry; Katherine A Gifford; Adam W Anderson; Bennett A Landman; Kaj Blennow; Henrik Zetterberg; Timothy J Hohman; John Jeffrey Carr; Angela L Jefferson
Journal:  Stroke       Date:  2021-10-27       Impact factor: 7.914

4.  Adverse Vascular Risk Relates to Cerebrospinal Fluid Biomarker Evidence of Axonal Injury in the Presence of Alzheimer's Disease Pathology.

Authors:  Katie E Osborn; Jonathan M Alverio; Logan Dumitrescu; Kimberly R Pechman; Katherine A Gifford; Timothy J Hohman; Kaj Blennow; Henrik Zetterberg; Angela L Jefferson
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

5.  Comparison of variables associated with cerebrospinal fluid neurofilament, total-tau, and neurogranin.

Authors:  Michelle M Mielke; Jeremy A Syrjanen; Kaj Blennow; Henrik Zetterberg; Ingmar Skoog; Prashanthi Vemuri; Mary M Machulda; Jonathan Graff-Radford; David S Knopman; Clifford R Jack; Ronald C Petersen; Silke Kern
Journal:  Alzheimers Dement       Date:  2019-10-23       Impact factor: 21.566

6.  Lower cardiac output is associated with neurodegeneration among older adults with normal cognition but not mild cognitive impairment.

Authors:  Elizabeth E Moore; Dandan Liu; Corey W Bown; Hailey A Kresge; Deepak K Gupta; Kimberly R Pechman; Lisa A Mendes; L Taylor Davis; Katherine A Gifford; Adam W Anderson; Thomas J Wang; Bennett A Landman; Timothy J Hohman; Angela L Jefferson
Journal:  Brain Imaging Behav       Date:  2020-10-10       Impact factor: 3.224

7.  Elevated plasma neurofilament light in aging reflects brain white-matter alterations but does not predict cognitive decline or Alzheimer's disease.

Authors:  Lars Nyberg; Anders Lundquist; Annelie Nordin Adolfsson; Micael Andersson; Henrik Zetterberg; Kaj Blennow; Rolf Adolfsson
Journal:  Alzheimers Dement (Amst)       Date:  2020-06-23

8.  Levels of plasma neurofilament light chain and cognitive function in patients with Alzheimer or Parkinson disease.

Authors:  Yung-Shuan Lin; Wei-Ju Lee; Shuu-Jiun Wang; Jong-Ling Fuh
Journal:  Sci Rep       Date:  2018-11-26       Impact factor: 4.379

9.  The 12-Word Philadelphia Verbal Learning Test Performances in Older Adults: Brain MRI and Cerebrospinal Fluid Correlates and Regression-Based Normative Data.

Authors:  Katherine A Gifford; Dandan Liu; Jacquelyn E Neal; Michelle A Babicz; Jennifer L Thompson; Lily E Walljasper; Margaret E Wiggins; Maxim Turchan; Kimberly R Pechman; Katie E Osborn; Lealani Mae Y Acosta; Susan P Bell; Timothy J Hohman; David J Libon; Kaj Blennow; Henrik Zetterberg; Angela L Jefferson
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2018-12-06

10.  Differential Impact of Plasma Homocysteine Levels on the Periventricular and Subcortical White Matter Hyperintensities on the Brain.

Authors:  Kee Ook Lee; Min-Hee Woo; Darda Chung; Jung-Won Choi; Nam-Keun Kim; Ok-Joon Kim; Seung-Hun Oh
Journal:  Front Neurol       Date:  2019-11-07       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.